TY - JOUR
T1 - Does spinal chloroprocaine pharmacokinetic profile actually translate into a clinical advantage in terms of clinical outcomes when compared to low-dose spinal bupivacaine? A systematic review and meta-analysis
AU - Saporito, Andrea
AU - Ceppi, Marcello
AU - Perren, Andreas
AU - La Regina, Davide
AU - Cafarotti, Stefano
AU - Borgeat, Alain
AU - Aguirre, José
AU - Van De Velde, Marc
AU - Teunkens, An
PY - 2019/2
Y1 - 2019/2
N2 - Study objective: Spinal anesthesia is well suited for day-care surgery, however a persisting motor block after surgery can delay discharge. Among the new drugs available, chloroprocaine has been associated with a short onset time, and motor block duration and a quicker discharge. However, it is not clear if those outcomes are clinically significantly superior compared to those associated with the use of low-dose hyperbaric bupivacaine. Design: Aim of the study was to determine if spinal 2-chloroprocaine was superior to low-dose spinal bupivacaine regarding the following outcomes: onset time, block duration, time to ambulation and time to discharge. Patients/interventions: We performed a systematic literature search of the last 30 years using PubMed Embase and the Cochrane Controlled Trials Register. We included only blinded, prospective trials comparing chloroprocaine with a low dose of bupivacaine for spinal anesthesia. Low dose bupivacaine was defined as a dose of 10 mg or less. Outcomes of interest were time to motor block regression (primary outcome), time to ambulation and time to discharge (secondary outcomes), as indirect indicators of a complete recovery after spinal anesthesia. Main results: Compared to a low dose bupivacaine, spinal 2-chloroprocaine was associated with significantly faster motor and sensory block regression (pMD = −57 min–140.3 min; P = 0.015 and <0.001 respectively), a significantly shorter time to ambulation and an earlier discharge (pMD = −84.6 min; P < 0.001 and pMD = −88.6 min and <0.001 respectively). Onset time did not differ between the two drugs (pMD = −1.1 min; P = 0.118). Conclusions: Spinal 2-chloroprocaine has a shorter motor block duration, a significantly quicker time to ambulation and time to discharge compared to low dose hyperbaric bupivacaine and may be advantageous when spinal anesthesia is performed for day case surgery.
AB - Study objective: Spinal anesthesia is well suited for day-care surgery, however a persisting motor block after surgery can delay discharge. Among the new drugs available, chloroprocaine has been associated with a short onset time, and motor block duration and a quicker discharge. However, it is not clear if those outcomes are clinically significantly superior compared to those associated with the use of low-dose hyperbaric bupivacaine. Design: Aim of the study was to determine if spinal 2-chloroprocaine was superior to low-dose spinal bupivacaine regarding the following outcomes: onset time, block duration, time to ambulation and time to discharge. Patients/interventions: We performed a systematic literature search of the last 30 years using PubMed Embase and the Cochrane Controlled Trials Register. We included only blinded, prospective trials comparing chloroprocaine with a low dose of bupivacaine for spinal anesthesia. Low dose bupivacaine was defined as a dose of 10 mg or less. Outcomes of interest were time to motor block regression (primary outcome), time to ambulation and time to discharge (secondary outcomes), as indirect indicators of a complete recovery after spinal anesthesia. Main results: Compared to a low dose bupivacaine, spinal 2-chloroprocaine was associated with significantly faster motor and sensory block regression (pMD = −57 min–140.3 min; P = 0.015 and <0.001 respectively), a significantly shorter time to ambulation and an earlier discharge (pMD = −84.6 min; P < 0.001 and pMD = −88.6 min and <0.001 respectively). Onset time did not differ between the two drugs (pMD = −1.1 min; P = 0.118). Conclusions: Spinal 2-chloroprocaine has a shorter motor block duration, a significantly quicker time to ambulation and time to discharge compared to low dose hyperbaric bupivacaine and may be advantageous when spinal anesthesia is performed for day case surgery.
KW - Ambulatory surgery
KW - Chloroprocaine
KW - Fast-track surgery
KW - Spinal anesthesia
UR - http://www.scopus.com/inward/record.url?scp=85053444944&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85053444944&partnerID=8YFLogxK
U2 - 10.1016/j.jclinane.2018.09.003
DO - 10.1016/j.jclinane.2018.09.003
M3 - Review article
C2 - 30237085
AN - SCOPUS:85053444944
SN - 0952-8180
VL - 52
SP - 99
EP - 104
JO - Journal of Clinical Anesthesia
JF - Journal of Clinical Anesthesia
ER -